|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||263.61 - 269.85|
|52 Week Range||199.85 - 271.70|
|Beta (3Y Monthly)||1.30|
|PE Ratio (TTM)||36.44|
|Earnings Date||Apr 23, 2019 - Apr 29, 2019|
|Forward Dividend & Yield||0.76 (0.28%)|
|1y Target Est||273.50|
PHILADELPHIA , March 19, 2019 /PRNewswire/ -- Pittcon 2019 -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is introducing innovative products, software and services ...
Expansion projects will increase capacity to meet growing customer demand for biologics WALTHAM, Mass. , March 18, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving ...
Thermo Fisher Scientific Inc NYSE:TMOView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for TMO with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting TMO. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold TMO had net inflows of $3.52 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Industrials sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
The longest bull market in U.S. history turned 10 this past weekend. Here are the Massachusetts public companies that have gained the most in value over the past decade.
The Zacks Analyst Blog Highlights: Amazon, Berkshire Hathaway, Thermo Fisher, Square and Public Service
Semtech's (SMTC) differentiated growth drivers and diversification strategy are likely to drive fiscal fourth-quarter results. However, exposure to seasonality and competition remain concerns.
Thermo Fisher Scientific Inc.'s (NYSE:TMO) announced its latest earnings update in December 2018, which revealed that the company experienced a robust tailwind, eventuating to a double-digit earnings growth of 32%.Read More...
WALTHAM, Mass. , March 4, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper , president and chief executive officer, will ...
Moody's Investors Service (Moody's) upgraded Thermo Fisher Scientific Inc.'s ("Thermo Fisher") senior unsecured rating to Baa1 from Baa2 and affirmed its Prime-2 ("P-2") commercial paper rating. "The upgrade of Thermo Fisher's senior unsecured rating to Baa1 reflects the successful integration of its Patheon acquisition," stated Moody's Vice President/Senior Analyst Jonathan Kanarek, CFA.
Thermo Fisher Scientific Inc is a healthcare company. The dividend yield of Thermo Fisher Scientific Inc stocks is 0.27%. Thermo Fisher Scientific Inc had annual average EBITDA growth of 13.80% over the past ten years.
WALTHAM, Mass. , Feb. 26, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash ...
When Dai started his company in 1994, roadside surveillance cameras were rare in China. The 54-year-old former academic, who now drives a luxury sedan and rewards high-performing employees with BMWs, is the latest of at least four businessmen to amass billion-dollar-plus fortunes from surveillance companies that count China’s government as a major client or investor.
BEIJING (AP) — Thermo Fisher Scientific Inc. says it will no longer sell or service genetic sequencers in China's mostly Muslim region of Xinjiang following criticism that they were used for surveillance that enabled human rights abuses, The Wall Street Journal reported.
Thermo Fisher Scientific Inc. said Wednesday it will no longer be selling or servicing genetic sequencers in China’s Xinjiang region, following mounting criticism that its products were used for state surveillance of citizens there that enabled human rights abuses. It didn’t specify whether it would continue to sell these sequencers elsewhere in China. The devices were described in a December 2017 Wall Street Journal article that highlighted the ways Chinese police gather DNA samples from many citizens who aren’t criminal suspects.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Thermo Fisher Scientific Inc. (NYSE:TMO), a large-capRead More...
Pacific Biosciences' (PACB) dismal fourth-quarter 2018 results can be attributed to disappointing performance by the company's Product Revenue segment.
Thermo Fisher Scientific (TMO) bills itself as "the world leader in serving science." The life-sciences titan provides a variety of equipment, supplies, and services for both the research and practical sides of the healthcare market, Richard Moroney, editor of Dow Theory Forecasts.